NEUROLOGIC ADVERSE-EFFECTS DURING CONCOMITANT TREATMENT WITH CIPROFLOXACIN, NSAIDS, AND CHLOROQUINE - POSSIBLE DRUG-INTERACTION

被引:30
作者
ROLLOF, J
VINGE, E
机构
[1] LUND UNIV HOSP,DEPT CLIN PHARMACOL,S-22185 LUND,SWEDEN
[2] LUND UNIV HOSP,DEPT INFECT DIS,S-22185 LUND,SWEDEN
[3] LUND UNIV HOSP,DRUG INFORMAT CTR SO SWEDEN,S-22185 LUND,SWEDEN
关键词
D O I
10.1177/106002809302700909
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To report a case of neurologic adverse effects that developed during concomitant treatment with ciprofloxacin, nonsteroidal antiinflammatory drugs (NSAIDs), and chloroquine. Possible mechanisms for a drug interaction are discussed. CASE SUMMARY: A 68-year-old woman who was receiving chronic treatment with NSAIDs and chloroquine developed dizziness, anxiety, and tremors when ciprofloxacin 500 mg twice daily was begun for Salmonella osteitis. When she discontinued the antirheumatic treatment, there was a prompt relief of symptoms. After indomethacin was reintroduced, the patient developed signs and symptoms of peripheral neuropathy, which partially subsided when ciprofloxacin was discontinued. DISCUSSION: Enhanced neurologic adverse effects of ciprofloxacin when taken together with NSAIDs or chloroquine may result from reduced effects of gamma-aminobutyric acid. An alternative explanation could be that NSAIDs and chloroquine impair the elimination of ciprofloxacin, thereby contributing to toxic concentrations of the antibiotic. CONCLUSIONS: The possibility of interactions between ciprofloxacin and antirheumatic drugs should be considered.
引用
收藏
页码:1058 / 1059
页数:2
相关论文
共 14 条
[1]  
CHENNAVASIN P, 1980, J PHARMACOL EXP THER, V215, P77
[2]   CHLOROQUINE ELIMINATION IN HUMANS - EFFECT OF LOW-DOSE CIMETIDINE [J].
ETTE, EI ;
BROWNAWALA, EA ;
ESSIEN, EE .
JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (10) :813-816
[3]   CONVULSIONS ASSOCIATED WITH PROPHYLACTIC ANTIMALARIAL-DRUGS - IMPLICATIONS FOR PEOPLE WITH EPILEPSY [J].
FISH, DR ;
ESPIR, MLE .
BRITISH MEDICAL JOURNAL, 1988, 297 (6647) :526-527
[4]  
Hook E.W., 1990, PRINCIPLES PRACTICE, P1700
[5]  
HORI S, 1987, 27TH INT C ANT AG CH, P101
[6]   INTERACTIONS OF CHLOROQUINE WITH BENZODIAZEPINE, GAMMA-AMINOBUTYRIC-ACID AND OPIATE RECEPTORS [J].
LIU, L ;
KATZ, Y ;
WEIZMAN, R ;
ROSENBERG, B ;
PASTERNAK, GW ;
GAVISH, M .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (10) :1534-1536
[7]  
MAKANJUOLA ROA, 1988, TROP GEOGR MED, V40, P31
[8]  
MORIKAWA K, 1987, 27TH INT C ANT AG CH, P141
[9]   P450-ENZYMES - INHIBITION MECHANISMS, GENETIC-REGULATION AND EFFECTS OF LIVER-DISEASE [J].
MURRAY, M .
CLINICAL PHARMACOKINETICS, 1992, 23 (02) :132-146
[10]  
RIOU B, 1988, NEW ENGL J MED, V318, P1, DOI 10.1056/NEJM198801073180101